Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Transferrin/transferrin receptor-mediated drug delivery.

Hongyan Li1, Zhong Ming Qian

  • 1Laboratory of Iron Metabolism, Department of Applied Biology and Chemical Technology, The Hong Kong Polytechnic University, Kowloon, Hong Kong.

Medicinal Research Reviews
|April 5, 2002
PubMed
Summary

Transferrin acts as a cellular delivery system for iron and other metal ions. It also targets anticancer drugs and genes to cancer cells by binding to transferrin receptors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

miR-3687 Overexpression Promotes Bladder Cancer Cell Growth by Inhibiting the Negative Effect of FOXP1 on Cyclin E2 Transcription.

Molecular therapy : the journal of the American Society of Gene Therapy·2019
Same author

The unique trimeric assembly of the virulence factor HtrA from <i>Helicobacter pylori</i> occurs via N-terminal domain swapping.

The Journal of biological chemistry·2019
Same author

A Novel Synthetic Compound, Bismuth Zinc Citrate, Could Potentially Reduce Cisplatin-Induced Toxicity Without Compromising the Anticancer Effect Through Enhanced Expression of Antioxidant Protein.

Translational oncology·2019
Same author

WITHDRAWN: MicroRNA-107 regulates autophagy and apoptosis of osteoarthritis chondrocytes by targeting TRAF3.

International immunopharmacology·2019
Same author

Clinical efficacy and safety of rituximab in lupus nephritis.

Drug design, development and therapy·2019
Same author

Engineering Na<sub>V</sub>1.7 Inhibitory JzTx-V Peptides with a Potency and Basicity Profile Suitable for Antibody Conjugation To Enhance Pharmacokinetics.

ACS chemical biology·2019

Area of Science:

  • Biochemistry and Molecular Biology
  • Cell Biology
  • Medical Research

Background:

  • Transferrin-mediated iron uptake is crucial for cellular function.
  • Recent discoveries of genes like HFE and DMT1 have advanced understanding of iron homeostasis.
  • Hereditary hemochromatosis is linked to HFE protein's modulation of transferrin receptor activity.

Purpose of the Study:

  • To explore transferrin's role beyond iron transport, including its potential as a delivery system for other metal ions.
  • To review transferrin's application as a targeting ligand for active drug and gene delivery to cancer cells.
  • To assess the potential of transferrin receptor-mediated delivery across the blood-brain barrier.

Main Methods:

  • Review of existing literature on transferrin function, iron homeostasis, and therapeutic applications.

Related Experiment Videos

  • Analysis of transferrin's interaction with various metal ions and its recognition by cells.
  • Examination of conjugation strategies for targeting anticancer agents, proteins, and genes using transferrin.
  • Main Results:

    • Transferrin serves as a versatile delivery system for beneficial and harmful metal ions.
    • Conjugating drugs or DNA to transferrin enhances targeting of cancer cells overexpressing transferrin receptors.
    • Transferrin receptor-mediated endocytosis offers potential for non-viral gene therapy and drug delivery, including across the blood-brain barrier.

    Conclusions:

    • Transferrin's role extends to delivering various metal ions and therapeutic payloads into cells.
    • Transferrin-based conjugates show promise in improving cancer treatment selectivity and overcoming drug resistance.
    • Targeted delivery via transferrin receptors presents a viable strategy for gene therapy and brain drug delivery.